Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine and postoperative liver function after living donor hepatectomy
ChiCTR2000040629Phase 4Recruiting
- Sponsor
- Beijing Friendship Hospital
- Start
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of dexmedetomidine in hepatic ischemia-reperfusion injury (HIRI) (2 arms), sponsored by Beijing Friendship Hospital. Primary endpoints: Postoperative liver transaminases and Severity of hepatic ischemia-reperfusion injury. Started Dec 2020; status: recruiting.
02
Drugs
dexmedetomidine
03
Conditions
hepatic ischemia-reperfusion injury (HIRI)
Beyond the preview
Go deeper on ChiCTR2000040629.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000040629.